This article refers to:
Jalloh MA, Ip EJ, Doroudgar S. What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality? Expert Opin Pharmacother. 2018 May;19(7):739–741.
https://doi.org/10.1080/14656566.2018.1464558
When the above article was published, the order of the authors was incorrect. This has now been corrected as given below.
Mohamed A. Jalloh, Shadi Doroudgar and Eric J. Ip